Comments
Dr Reddy’s Laboratories has launched Palonosetron Hydrochloride injection, a therapeutic equivalent generic version of ALOXI (palonosetron hydrochloride) injection approved by the US Food and Drug Administration (USFDA). The Aloxi brand and generic had US sales of approximately $446 million for the most recent 12 months ending in January 2018, according to IMS Health.
Dr Reddy’s Palonosetron Hydrochloride injection is available in a strength of 0.25 mg/5 mL (free base) in a single-dose vial packaged in a carton containing one vial, according to a release. ALoxi is a registered trademark of Helsinn Healthcare SA.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.